Haruyasu Yamaguchi

9.5k citations

134 papers · 7.5k indexed · 1 hit paper · h-index 49

Physiology top 0.2%
- Alzheimer's disease research and treatments 76
Neurology top 0.5%
Cellular and Molecular Neuroscience top 1%
- Neuroscience and Neuropharmacology Research 9
- Nuclear Receptors and Signaling 8
Biological Psychiatry top 2%
Psychiatry and Mental health top 1%
- Dementia and Cognitive Impairment Research 37
Molecular Biology
- Prion Diseases and Protein Misfolding 25
- Amyloidosis: Diagnosis, Treatment, Outcomes 15
- S100 Proteins and Annexins 9
Rehabilitation
- Stroke Rehabilitation and Recovery 8

Co-authors: Yoichi Nakazato Kiyoshi Takahashi Dietmar Rudolf Thal Takashi Nakajima Yohko Maki Akihiko Takashima Mikio Shoji Cynthia A. Lemere
Cited by: Physiology Neurology Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (4 papers)Journal of Neuroscience (4 papers)
Partner nations: Japan United States Germany

In The Last Decade

Haruyasu Yamaguchi

131 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Haruyasu Yamaguchi

Since Specialization

Citations

This map shows the geographic impact of Haruyasu Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruyasu Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruyasu Yamaguchi more than expected).

Fields of papers citing papers by Haruyasu Yamaguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruyasu Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruyasu Yamaguchi. The network helps show where Haruyasu Yamaguchi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haruyasu Yamaguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haruyasu Yamaguchi Line = papers co-authored together Haruyasu Yamaguchi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development, Validity, and Reliability of a Japanese Version of the End-of-Life in Dementia Scales The Kitakanto Medical Journal ·Sayaka Toya,Yoko Uchida,Tsuneo Yamazaki,Tomoyuki Saito,Yuhei Chiba,Tomoyuki Kawashima,Yukari Takai,Haruyasu Yamaguchi	2022	1
2	Effects of Music Therapy in Frail Elderlies: Controlled Crossover Study Dementia and Geriatric Cognitive Disorders Extra ·Nobuyuki Murabayashi,Takako Akahoshi,Risa Ishimine,Nobuko Saji,Chiyomi Takeda,Hisako Nakayama,Megumi Noro,Hiroko Fujimoto,Megumi Misaki,Keiko Miyamoto,Yukiko Yamada,Itaru Kohya,Mayu Kondo,Haruyasu Yamaguchi,Daisuke Sasaki,Yasuji Murai	2019	17
3	Rehabilitation to live better with dementia Geriatrics and gerontology international ·Yohko Maki,Takashi Sakurai,Jiro Okochi,Haruyasu Yamaguchi,Kenji Toba	2018	27
4	Tannic Acid Is a Natural β-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice Journal of Biological Chemistry ·T. Mori,Kavon Rezai‐Zadeh,Naoki Koyama,Gary W. Arendash,Haruyasu Yamaguchi,Nobuto Kakuda,Yuko Horikoshi‐Sakuraba,Jun Tan,Terrence Town	2012	140
5	Yamaguchi fox–pigeon imitation test (YFPIT) for dementia in clinical practice Psychogeriatrics ·Haruyasu Yamaguchi,Satoshi Takahashi,Kenji Kosaka,Koichi Okamoto,Tsuneo Yamazaki,Masaki Ikeda,M. Osawa,Masakuni Amari,Yasuo Harigaya,Shuichi Awata,Yohko Maki	2011	10
6	Assembly of hereditary amyloid β‐protein variants in the presence of favorable gangliosides FEBS Letters ·Naoki Yamamoto,Yoshio Hirabayashi,Masakuni Amari,Haruyasu Yamaguchi,Galina Romanov,William E. Van Nostrand,Katsuhiko Yanagisawa	2005	57
7	Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant Biochemical and Biophysical Research Communications ·Yuko Horikoshi,Gaku Sakaguchi,Amanda G. Becker,Audrey Gray,Karen Duff,Paul Aisen,Haruyasu Yamaguchi,Masahiro Maeda,Noriaki Kinoshita,Yasuji Matsuoka	2004	80
8	Plasmodium falciparum: selenium-induced cytotoxicity to P. falciparum Experimental Parasitology ·Nao Taguchi,Toshimitsu Hatabu,Haruyasu Yamaguchi,Mamoru Suzuki,Kumiko Sato,Shigeyuki Kano	2004	11
9	Aβ N-terminal-end specific antibody reduced β-amyloid in Alzheimer-model mice Biochemical and Biophysical Research Communications ·Yuko Horikoshi,Takashi Mori,Masahiro Maeda,Noriaki Kinoshita,Kumiko Sato,Haruyasu Yamaguchi	2004	22
10	Glial reactions and the clearance of amyloid β protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type Acta Neuropathologica ·Marion L. C. Maat–Schieman,Haruyasu Yamaguchi,Ingrid M. Hegeman-Kleinn,Corrie Welling‐Graafland,Remco Natté,Raymund A.C. Roos,Sjoerd G. van Duinen	2004	30
11	Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathologybreakdown → American Journal Of Pathology ·Reisuke H. Takahashi,Teresa A. Milner,Feng Li,Ellen E. Nam,Mark Edgar,Haruyasu Yamaguchi,M. Flint Beal,Huaxi Xu,Paul Greengard,Gunnar K. Gouras	2002	583
12	Accumulation of Amyloid β-Protein in the Low-Density Membrane Domain Accurately Reflects the Extent of β-Amyloid Deposition in the Brain American Journal Of Pathology ·Noriko Oshima,Maho Morishima‐Kawashima,Haruyasu Yamaguchi,Masahiro Yoshimura,Shiro Sugihara,Karen Khan,Dora Games,Dale Schenk,Yasuo Ihara	2001	41
13	Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex Acta Neuropathologica ·Dietmar Rudolf Thal,Christian Schultz,Faramarz Dehghani,Haruyasu Yamaguchi,Heiko Braak,Eva Braak	2000	99
14	Transthyretin binds amyloid β peptides, Aβ1–42 and Aβ1–40 to form complex in the autopsied human kidney – possible role of transthyretin for Aβ sequestration Neuroscience Letters ·Kayo Tsuzuki,Ryo Fukatsu,Haruyasu Yamaguchi,Masatoshi Tateno,Kohzoh Imai,Nobuhiro Fujii,Toshio Yamauchi	2000	53
15	Appearance of Sodium Dodecyl Sulfate-Stable Amyloid β-Protein (Aβ) Dimer in the Cortex During Aging American Journal Of Pathology ·Miho Enya,Maho Morishima‐Kawashima,Masahiro Yoshimura,Yasuhisa Shinkai,Kaoru Kusui,Karen Khan,Dora Games,Dale Schenk,Shiro Sugihara,Haruyasu Yamaguchi,Yasuo Ihara	1999	86
16	Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease Neuroscience Letters ·Koichi Ishiguro,Hideto Ohno,Hiroyuki Arai,Haruyasu Yamaguchi,Katsuya Urakami,Jungmi Park,Kazuki Sato,Hideki Kohno,Kazutomo Imahori	1999	140
17	Diagnostic significance of skin immunolabelling with antibody against native cerebral amyloid in Alzheimer's disease Neuroscience Letters ·Masaki Ikeda,Mikio Shoji,Haruyasu Yamaguchi,Etsuro Matsubara,Masakuni Amari,Koji Ishiguro,Takeshi Kawarabayashi,Yasuo Harigaya,Shunsaku Hirai	1993	11
18	Differential expression of α 1-antichymotrypsin in the aged human brain Virchows Archiv B Cell Pathology Including Molecular Pathology ·Koji Ishiguro,Mikio Shoji,Haruyasu Yamaguchi,Etsuro Matsubara,Masaki Ikeda,Takeshi Kawarabayashi,Yasuo Harigaya,Koichi Okamoto,S Hirai	1993	8
19	Ultrastructural localization of Alzheimer amyloid ?/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes Acta Neuropathologica ·Haruyasu Yamaguchi,Tsuneo Yamazaki,Koji Ishiguro,Mikio Shoji,Yoichi Nakazato,Shunsaku Hirai	1992	48
20	Expression of APP in the early stage of brain damage Brain Research ·Takeshi Kawarabayashi,Mikio Shoji,Yasuo Harigaya,Haruyasu Yamaguchi,Shunsaku Hirai	1991	130

About Haruyasu Yamaguchi

Haruyasu Yamaguchi is a scholar working on Physiology, Psychiatry and Mental health and Neurology, having authored 134 papers that have together received 7.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (76 papers), Dementia and Cognitive Impairment Research (37 papers), Prion Diseases and Protein Misfolding (25 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), S100 Proteins and Annexins (9 papers), Neuroscience and Neuropharmacology Research (9 papers), Stroke Rehabilitation and Recovery (8 papers) and Nuclear Receptors and Signaling (8 papers). The work is most often cited by research in Physiology (4.8k citations), Neurology (1.1k citations) and Cellular and Molecular Neuroscience (1.4k citations). Haruyasu Yamaguchi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Yoichi Nakazato, Kiyoshi Takahashi, Dietmar Rudolf Thal, Takashi Nakajima, Yohko Maki, Akihiko Takashima, Mikio Shoji, Cynthia A. Lemere, Shunsaku Hirai and Koichi Ishiguro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact